Overexpression of yes‐associated protein contributes to progression and poor prognosis of non‐small‐...
Overexpression of yes‐associated protein contributes to progression and poor prognosis of non‐small‐cell lung cancer
About this item
Full title
Author / Creator
Wang, Yang , Dong, Qianze , Zhang, Qingfu , Li, Zixuan , Wang, Enhua and Qiu, Xueshan
Publisher
Oxford, UK: Blackwell Publishing Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Oxford, UK: Blackwell Publishing Ltd
Subjects
More information
Scope and Contents
Contents
Yes‐associated protein (YAP), the nuclear effector of the Hippo pathway, is a key regulator of organ size and a candidate human oncogene. This study aimed to assess the clinical significance and biological functions of YAP in non‐small‐cell lung cancer (NSCLC). We investigated the expression of YAP in 92 cases of NSCLC tissue by immunohistochemistr...
Alternative Titles
Full title
Overexpression of yes‐associated protein contributes to progression and poor prognosis of non‐small‐cell lung cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11158334
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11158334
Other Identifiers
ISSN
1347-9032,1349-7006
E-ISSN
1349-7006
DOI
10.1111/j.1349-7006.2010.01511.x
